Subcutaneous Ancrod after Operation for Fractured Hip - a Dose-Ranging and Feasibility Study

Summary

We have conducted a dose-ranging and feasibility study of daily subcutaneous injections of ancrod (Arvin) as a potential antithrombotic method in 28 patients following operation for fractured neck of femur. Sustained, predictable fibrinogen depletion during the first post-operative week was induced by four different regimes. A total dose of 10 units/kg weight, given in divided doses starting on the day of operation, is suggested as a possible antithrombotic regime. Ancrod treatment produced a rise in fibrinogen/fibrin degradation products, prolongation of the thrombin clotting time, and a fall in plasminogen, plasma viscosity, blood viscosity and haematocrit-corrected blood viscosity. A rise in plasma fibrinogen and corrected blood viscosity were observed in 14 control patients. Plasma fibrinogen was correlated with plasma viscosity and corrected blood viscosity. No adverse effects of treatment occurred. Subcutaneous ancrod appears to be a simple, safe, and feasible potential antithrombotic method, and merits trials of efficacy in the prevention of post-operative thromboembolism.

• References

• 1 Alkjaersig NO, Fletcher AP, Sherry S. 1959; The mechanism of clot dissolution by plasmin. Journal of Clinical Investigation 38: 1086
• 2 Barrie WW, Wood EH, Crumlish P, Forbes CD, Prentice CR M. 1974; Low-dosage ancrod for prevention of thrombotic complications after surgery for fractured neck of femur. British Medical Journal 2: 130
• 3 Clayton JK, Anderson JA, Mcnicol GP. 1976; Pre-operative prediction of postoperative deep vein thrombosis. British Medical Journal 2: 910
• 4 Dintenfass L. 1969; A co-axial rhombospheroid viscometer: a further development of the cone-incone viscometer. Biorheology 6: 33
• 5 Dormandy JA. 1970; Clinical significance of blood viscosity. Annals of the Royal College of Surgeons 47: 211
• 6 Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. 1973; Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. British Medical Journal 4: 576
• 7 Dormandy JA, Edelman JB. 1973; High blood viscosity: an aetiological factor in venous thrombosis. British Journal of Surgery 60: 187
• 8 Ehrly AM. 1972; Influence of Arwin on the flow properties of blood. Biorheology 9: 151
• 9 Fletcher AP, Alkjaersig N, Sherry S. 1959; The maintenance of a sustained thrombolytic state in man. Journal of Clinical Investigation 38: 1096
• 10 Gallus AS, Hirsh J, Tuttle RJ, Trebilcock R, O’brien SE, Carrol JJ, Minden JJ, Hudecki SM. 1973; Small subcutaneous doses of heparin in prevention of venous thrombosis. New England Journal of Medicine 288: 545
• 11 International Multicentre Trial. 1975; Prevention of fatal post-operative pulmonary embolism by low doses of heparin. Lancet 2: 45
• 12 Kakkar VV, Corrigan T, Spindler J, Fossard DP, Flute PT, Crellin RQ, Wessler S, Yin ET. 1972; Efficacy of low doses of heparin in prevention of deep vein thrombosis after major surgery. Lancet 2: 101
• 13 Karpinnen K. 1970; The electrophoretic mobility of red cells and platelets and the plasma viscosity in coronary heart disease. Acta medica Scandinavica Suppl 506
• 14 Kemble JV H, Hickman JA. 1972; Postoperative changes in blood viscosity and the influence of haematocrit and plasma-fibrinogen. British Journal of Surgery 59: 629
• 15 Kline A, Hughes LE, Campbell H, Williams A, Zlosnick J, Leach KG. 1975; Dextran 70 in prophylaxis of thromboembolic disease after surgery: a clinically oriented randomised doubleblind trial. British Medical Journal 2: 109
• 16 Lowe GD O, Morrice JJ, Forbes CD, Prentice CR M, Barbenel J. 1977. Changes in blood viscosity and blood flow associated with therapeutic defibrination. In: Forbes CD, Mackay N. (eds.) The Detection and Treatment of Thromboembolism. The Trust for Education and Research in Therapeutics; London: p 39
• 17 Merskey C, Kleiner CJ, Johnson AJ. 1966; Quantitative estimation of split products of fibrinogen in. Blood 28: 1
• 18 Morris GK, Mitchell JR A. 1976; a Prevention and diagnosis of venous thrombosis in patients with hip fractures. Lancet 2: 867
• 19 Morris GK, Mitchell JR A. 1976; b Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur. Lancet 2: 869
• 20 Morris GK, Mitchell JR A. 1977; Preventing venous thromboembolism in elderly patients with hip fractures: Studies of low-dose heparin, dipyridamole, aspirin and flurbiprofen. British Medical Journal 7: 535
• 21 Pitney WR, Bell WR, Bolton G. 1969; Blood fibrinolytic activity during Arvin therapy. British Journal of Haematology 16: 165
• 22 Pollock A, Harrison MH M. 1976; Hip fractures and deep-vein thromboembolism. Lancet 2: 1301
• 23 Ratnoff OD, Menzie C. 1951; A new method for the determination of fibrinogen in small samples of plasma. Journal of Laboratory and Clinical Medicine 31: 316
• 24 Reid HA, Chan KE, Thean PC. 1963; Prolonged coagulation defect (defibrination syndrome) in Malayan viper bite. Lancet 1: 621
• 25 Remmert LF, Cohen PP. 1949; Partial purification and properties of a proteolytic enzyme of human serum. Journal of Biological Chemistry 181: 143
• 26 Rizza CR. 1972. The clinical features of clotting factor deficiencies. In: Biggs R. (ed) Human Blood Coagulation, Haemostasis and Thrombosis. Blackwell Scientific; Oxford: p 210
• 27 Sevtit S, Gallagher NG. 1959; Prevention of venous thrombosis and pulmonary embolism in injured patients. Lancet 2: 981
• 28 Simon TL, Stengle JM. 1974; Antithrombotic practice in orthopaedic surgery. Clinical Orthopaedics and Related Research 102: 181
• 29 Weaver JP A, Evans A, Walder DN. 1969; The effect of increased fibrinogen content on the viscosity of blood. Clinical Science 36: 1
• 30 Wood EH, Prentice CR M, McNicol GP. 1972; Association of fibrinogen-fibrin related antigen (F R antigen) with postoperative deep-vein thrombosis and systemic complications. Lancet 1: 166